51
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qi XR, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. First measurement of form factors of the decay Xi(0) --> Sigma(+)e(-)nu macro(e). PHYSICAL REVIEW LETTERS 2001; 87:132001. [PMID: 11580577 DOI: 10.1103/physrevlett.87.132001] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/10/2001] [Indexed: 05/23/2023]
Abstract
We present the first measurement of the form factor ratios g(1)/f(1) (direct axial vector to vector), g(2)/f(1) (second class current), and f(2)/f(1) (weak magnetism) for the decay Xi(0)-->Sigma(+)e(-)nu macro(e) using the KTeV (E799) beam line and detector at Fermilab. From the Sigma(+) polarization measured with the decay Sigma(+)-->p pi(0) and the e(-)-nu; correlation, we measure g(1)/f(1) to be 1.32+/-(0.21)(0.17)(stat)+/-0.05(syst), assuming the SU(3)(f) (flavor) values for g(2)/f(1) and f(2)/f(1). Our results are all consistent with exact SU(3)(f) symmetry.
Collapse
|
52
|
Chang LL, Sidler KL, Cascieri MA, de Laszlo S, Koch G, Li B, MacCoss M, Mantlo N, O'Keefe S, Pang M, Rolando A, Hagmann WK. Substituted imidazoles as glucagon receptor antagonists. Bioorg Med Chem Lett 2001; 11:2549-53. [PMID: 11549467 DOI: 10.1016/s0960-894x(01)00498-x] [Citation(s) in RCA: 93] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A modestly active, nonselective triarylimidazole lead was optimized for binding affinity with the human glucagon receptor. This led to the identification of a 2- and/or 4-alkyl or alkyloxy substituent on the imidazole C4-aryl group as a structural determinant for significant enhancement in binding with the glucagon receptor (e.g., 41, IC(50)=0.053 microM) and selectivity (>1000x) over p38MAP kinase in this class of compounds.
Collapse
|
53
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barbosa RF, Barker AR, Barrio M, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Qi XR, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Branching ratio measurement of the decay K(L) --> e(+)e(-)mu(+)mu(-). PHYSICAL REVIEW LETTERS 2001; 87:111802. [PMID: 11531512 DOI: 10.1103/physrevlett.87.111802] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2001] [Indexed: 05/23/2023]
Abstract
We have collected a 43 event sample of the decay K(L)-->e(+)e(-)mu(+)mu(-) with negligible backgrounds and measured its branching ratio to be (2.62+/-0.40+/-0.17)x10(-9). We see no evidence for CP violation in this decay. In addition, we set the 90% confidence upper limit on the combined branching ratios for the lepton flavor violating decays K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+) at B(K(L)-->e(+/-)e(+/-)mu(-/+)mu(-/+))< or =1.23x10(-10), assuming a uniform phase space distribution.
Collapse
|
54
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the branching ratio and form factor of K(L)-->mu(+)mu(-)gamma. PHYSICAL REVIEW LETTERS 2001; 87:071801. [PMID: 11497879 DOI: 10.1103/physrevlett.87.071801] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2001] [Indexed: 05/23/2023]
Abstract
We report on the analysis of the rare decay K(L)-->mu(+)mu(-)gamma the 1997 data from the KTeV experiment at Fermilab. A total of 9327 candidate events are observed with 2.4% background, representing a factor of 40 increase in statistics over the current world sample. We find that B(K(L)-->mu(+)mu(-)gamma) = (3.62 +/- 0.04(stat) +/- 0.08(syst)) x 10(-7). The form factor parameter alpha(K*) is measured to be alpha(K*) = -0.160(+0.026)(-0.028). In addition, we make the first measurement of the parameter alpha from the D'Ambrosio-Isidori-Portolés form factor, finding alpha = -1.54 +/- 0.10. In that model, this alpha measurement limits the Cabibbo-Kobayashi-Maskawa parameter rho>-0.2.
Collapse
|
55
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurements of the rare decay K(L) --> e(+)e(-)e(+)e(-). PHYSICAL REVIEW LETTERS 2001; 86:5425-5429. [PMID: 11415267 DOI: 10.1103/physrevlett.86.5425] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/05/2001] [Indexed: 05/23/2023]
Abstract
We observe 441 K(L)-->e(+)e(-)e(+)e(-) candidate events with a background of 4.2 events and measure B(K(L)-->e(+)e(-)e(+)e(-)) = [3.72+/-0.18(stat)+/-0.23(syst)]x10(-8) in the KTeV/E799II experiment at Fermilab. Using the distribution of the angle between the planes of the e(+)e(-) pairs, we measure the CP parameters beta(CP) = -0.23+/-0.09(stat)+/-0.02(syst) and gamma(CP) = -0.09+/-0.09(stat)+/-0.02(syst). We also present the first detailed study of the e(+)e(-) invariant mass spectrum in this decay mode.
Collapse
|
56
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Measurement of the branching ratio and asymmetry of the decay Xi degrees -->Sigma degrees gamma. PHYSICAL REVIEW LETTERS 2001; 86:3239-3243. [PMID: 11327940 DOI: 10.1103/physrevlett.86.3239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/11/2000] [Indexed: 05/23/2023]
Abstract
We have studied the rare weak radiative hyperon decay Xi degrees -->Sigma degrees gamma in the KTeV experiment at Fermilab. We have identified 4045 signal events over a background of 804 events. The dominant Xi degrees -->Lambdapi degrees decay, which was used for normalization, is the only important background source. An analysis of the acceptance of both modes yields a branching ratio of B(Xi degrees -->Sigma degrees gamma)/B(Xi degrees -->Lambdapi degrees ) = (3.34+/-0.05+/-0.09)x10(-3). By analyzing the final state decay distributions, we have also determined that the Sigma degrees emission asymmetry parameter for this decay is alpha(XiSigma) = -0.63+/-0.09.
Collapse
|
57
|
Li S, Thanikachalam M, Pang M, Carreno M, Aitouche A, Pham SM. Combined host-conditioning with CTLA4-Ig, tacrolimus, anti-lymphocyte serum, and low-dose radiation leads to stable mixed hematopoietic chimerism. Exp Hematol 2001; 29:534-41. [PMID: 11301194 DOI: 10.1016/s0301-472x(00)00685-8] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The toxic dose of irradiation required to achieve stable mixed hematopoietic chimerism is the major limitation to its clinical application in transplantation and other nonmalignant conditions such as hemoglobinopathies. This study examines the additive effect of costimulatory blockage, to our previously described tacrolimus-based conditioning regimen, in further reducing the dose of total-body irradiation to achieve stable mixed chimerism in rats. Fully mismatched, 4- to 6-week-old ACI and Wistar Furth rats were used as donors and recipients, respectively. Recipients were administered CTLA4-Ig 2mg/kg/day (alternate days) in combination with tacrolimus 1 mg/kg/day (daily) from day 0 through day +10, anti-lymphocyte serum 10 mg at day +10 (single dose), and total-body irradiation ranging from 100-600 cGy, prior to bone marrow transplantation (day 0) with 100 x 10(6) of T-cell-depleted bone marrow cells. Levels of donor chimerism were determined over a period of 12 months. The short course of CTLA4-Ig, tacrolimus, and ALS led to dramatic engraftments at reduced doses of irradiation: 100% (5/5) and 93% (13/14) of the animals developed mixed chimerism at 400 cGy and 300 cGy, respectively. At 300 cGy, recipients exhibited durable, multilineage mixed chimerism at 365 days with donor cells ranging from 19-42% (mean 23.4%) with no evidence of graft-vs-host disease. These mixed chimeras exhibited in vitro (mixed lymphocyte reaction) and in vivo (skin grafts) donor-specific tolerance. This study suggests that addition of costimulatory blockade to a tacrolimus-based conditioning regimen reduces the dose of irradiation required to achieve stable multilineage chimerism in rats.
Collapse
|
58
|
Chan R, Khoo L, Ho TH, Koh CF, Lee IW, Yam KL, Chandra D, Pang M, Chow V. A comparative study of cervical cytology, colposcopy and PCR for HPV in female sex workers in Singapore. Int J STD AIDS 2001; 12:159-63. [PMID: 11231868 DOI: 10.1258/0956462011916956] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
This study examined the prevalence of human papillomavirus (HPV) infection in a cohort of female sex workers in Singapore. HPV infection was diagnosed by clinical examination, Papanicolaou (Pap) smears, histology and polymerase chain reaction (PCR). One hundred and eighty-seven female sex workers who came for their routine medical screening were enrolled into the study. PCR was positive for HPV in 27 (14.4%), 20 of these had a single HPV type detected, while 7 had multiple types of HPV detected. The most common HPV types identified were types 16, 58 and 18. In conclusion, HPV infection is moderately prevalent among sex workers as tested by PCR, but routine screening with Pap smears does not appear to be a sensitive method of diagnosis for HPV infection.
Collapse
|
59
|
Fukada J, Schena S, Tack I, Ruiz P, Kurimoto Y, Pang M, Aitouche A, Abe T, Striker LJ, Pham SM. Nitric oxide donor FK409 attenuates the development of neointimal hyperplasia in a rat aortic allograft model. Transplant Proc 2001; 33:536-7. [PMID: 11266945 DOI: 10.1016/s0041-1345(00)02129-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
60
|
Alavi-Harati A, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hamm J, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Shields J, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Turner SE, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Study of the K(0)(L) --> pi(+)pi(-)gamma Direct Emission Vertex. PHYSICAL REVIEW LETTERS 2001; 86:761-764. [PMID: 11177934 DOI: 10.1103/physrevlett.86.761] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/25/2000] [Indexed: 05/23/2023]
Abstract
We have performed studies of the K(0)(L)-->pi(+)pi(-)gamma direct emission ( DE) and inner Bremsstrahlung ( IB) vertices, based on data collected by KTeV during the 1996 Fermilab fixed target run. We find a(1)/a(2) = -0.737+/-0.034 GeV2 for the DE form-factor parameter in the rho-propagator parametrization, and report on fits of the form factor to linear and quadratic functions as well. We concurrently measure gamma(K(0)(L)-->pi(+)pi(-)gamma,E(*)(gamma)>20 MeV)/gamma(K(0)(L)-->pi(+)pi(-)) = (20.8+/-0.3)x10(-3), and a K(0)(L)-->pi(+)pi(-)gamma DE/(DE+IB) branching ratio of 0.683+/-0.011.
Collapse
|
61
|
Alavi-Harati A, Albuquerque IF, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Fordyce PM, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hanagaki K, Hidaka S, Hsiung YB, Jejer V, Jennings J, Jensen DA, Kessler R, Kobrak HG, LaDue J, Lath A, Ledovskoy A, McBride PL, McManus AP, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O'Dell V, Pang M, Pordes R, Prasad V, Qiao C, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Swanson RA, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Search for the decay KL --> pi(0)e+e-. PHYSICAL REVIEW LETTERS 2001; 86:397-401. [PMID: 11177840 DOI: 10.1103/physrevlett.86.397] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/11/2000] [Indexed: 05/23/2023]
Abstract
We report on a search for the decay KL-->pi(0)e+e- carried out by the KTeV/E799 experiment at Fermilab. This decay is expected to have a significant CP violating contribution and the measurement of its branching ratio could support the Cabibbo-Kobayashi-Maskawa mechanism for CP violation or could point to new physics. Two events were observed in the 1997 data with an expected background of 1.06+/-0.41 events, and we set an upper limit B(KL-->pi(0)e+e-)<5.1 x 10(-10) at the 90% confidence level.
Collapse
|
62
|
Lee JK, Schnee J, Pang M, Wolfert M, Baum LG, Moremen KW, Pierce M. Human homologs of the Xenopus oocyte cortical granule lectin XL35. Glycobiology 2001; 11:65-73. [PMID: 11181563 DOI: 10.1093/glycob/11.1.65] [Citation(s) in RCA: 77] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
The cDNAs encoding two human homologs of the Xenopus oocyte lectin, XL35, were isolated from a small intestine cDNA library and termed HL-1 and HL-2. The deduced amino acid sequence of each homolog is about 60% identical and 80% similar to that of XL35, and none of these sequences contains the C-type lectin motif, although it is known that XL35 requires calcium for ligand binding. By Northern analysis, HL-1 transcripts are present at relatively high levels in heart, small intestine, colon, thymus, ovary, and testis. HL-2 transcripts, by contrast, are expressed only in small intestine. Immunocytochemistry using a polyclonal antibody produced against XL35 shows HL-1 protein to be localized exclusively in endothelial cells in colon, thymus, liver, and other tissues. Primary cultures of human aortic endothelial cells are positive for HL-1 expression by immunoblotting and by PCR analysis, but several other human cell types are not. HL-1 and -2 are both encoded at chromosome 1q23, the same locus that encodes the selectins. XL35, HL-1 and -2, and another mouse homolog are members of a new family of proteins whose members most likely perform diverse functions.
Collapse
|
63
|
Lin S, Lian Q, Pang M. [Exploration on parameters of TCM syndrome in acute cerebral infarction through investigating active factors of vascular endothelium cells]. ZHONGGUO ZHONG XI YI JIE HE ZA ZHI ZHONGGUO ZHONGXIYI JIEHE ZAZHI = CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE 2000; 20:911-4. [PMID: 11938862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
Abstract
OBJECTIVE To explore the multiple parameters of TCM Syndrome-types and the acute cerebral infarction (ACI) with blood stasis type. METHODS Sixty-six acute cerebral infarction patients with blood stasis Syndrome, various vascular active factors such as tissue plasminogen activator (t-PA), the activity of plasminogen activator inhibitor (PAI), the concentration of prostaglandin F1 alpha (6-keto-PGF1 alpha) etc. were determined. RESULTS (1) In Incidental Syndrome, those "Phlegm" and "stasis" predominant, mainly manifested as Wind-Phlegm-Blood stasis (WPBS), Qi deficiency-blood stasis (QDBS) and Phlegm-Heat-bowel excess (PHBE) Syndrome all showed t-PA activity lowered, among them, QDBS Syndrome lowered more obviously (P < 0.01); and in fundamental deficiency predominant Syndrome such as Yin-deficiency and Wind-move (YDWM) Syndrome, the active t-PA content increased (P < 0.05); in Liver Yang ascending (LYA) Syndrome and YDWM Syndrome, the 6-keto-PGF1 alpha lowered very significantly. (2) Through regression analysis, although influencing the severity of acute blood stasis was related with 3 factors (t-PA activity, nervous system defect score and age growth), but single factor linear relationship analysis indicated that did not existed positive-negative relationship. (3) Through statistical analysis, the factor influencing nervous system defect scores was positively related with blood stasis score (r = 0.70, P < 0.01). CONCLUSION (1) The basis of WPBS, QDBS and PHBE Syndrome mainly was fibrinolytic system activity lowering, and YDWM and LYA Syndrome prostaglandin system activity lowering. Comprehensive analysis of multiple parameters would be helpful to differentiate the ACI blood stasis stage. (2) Single parameter would not help to differentiate the types of ACI blood stasis stage, its change merely denoted the existence of blood stasis, its type should be differentiated after comprehensive analysis. (3) Those influencing nervous system scoring, mainly was blood stasis score, which suggested that the importance of activating blood circulation to remove stasis in preventing and treating ACI. (4) Put forward ACI blood stasis, and the quantification for new standard of Syndrome for discussion.
Collapse
|
64
|
Alavi-Harati A, Albuquerque IF, Alexopoulos T, Arenton M, Arisaka K, Averitte S, Barker AR, Bellantoni L, Bellavance A, Belz J, Ben-David R, Bergman DR, Blucher E, Bock GJ, Bown C, Bright S, Cheu E, Childress S, Coleman R, Corcoran MD, Corti G, Cox B, Crisler MB, Erwin AR, Ford R, Glazov A, Golossanov A, Graham G, Graham J, Hagan K, Halkiadakis E, Hanagaki K, Hazumi M, Hidaka S, Hsiung YB, Jejer V, Jennings J, Jensen DA, Kessler R, Kobrak HGE, LaDue J, Lath A, Ledovskoy A, McBride PL, McManus AP, Mikelsons P, Monnier E, Nakaya T, Nelson KS, Nguyen H, O’Dell V, Pang M, Pordes R, Prasad V, Qiao C, Quinn B, Ramberg EJ, Ray RE, Roodman A, Sadamoto M, Schnetzer S, Senyo K, Shanahan P, Shawhan PS, Slater W, Solomey N, Somalwar SV, Stone RL, Suzuki I, Swallow EC, Swanson RA, Taegar SA, Tesarek RJ, Thomson GB, Toale PA, Tripathi A, Tschirhart R, Wah YW, Wang J, White HB, Whitmore J, Winstein B, Winston R, Yamanaka T, Zimmerman ED. Evidence for the decayKL→μ+μ−γγ. Int J Clin Exp Med 2000. [DOI: 10.1103/physrevd.62.112001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
65
|
Pace KE, Hahn HP, Pang M, Nguyen JT, Baum LG. CD7 delivers a pro-apoptotic signal during galectin-1-induced T cell death. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2000; 165:2331-4. [PMID: 10946254 DOI: 10.4049/jimmunol.165.5.2331] [Citation(s) in RCA: 169] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Galectin-1, an endogenous lectin expressed in lymphoid organs and immune-privileged sites, induces death of human and murine thymocytes and T cells. Galectin-1 binds to several glycoproteins on the T cell surface, including CD7. However, the T cell surface glycoprotein receptors responsible for delivering the galectin-1 death signal have not been identified. We show that CD7 is required for galectin-1-mediated death. This demonstrates a novel function for CD7 as a death trigger and identifies galectin-1/CD7 as a new biologic death signaling pair.
Collapse
|
66
|
Fukada J, Schena S, Tack I, Ruiz P, Kurimoto Y, Pang M, Aitouche A, Abe T, Striker LJ, Pham SM. FK409, a spontaneous nitric oxide releaser, attenuates allograft vasculopathy in a rat aortic transplant model. Circ Res 2000; 87:66-72. [PMID: 10884374 DOI: 10.1161/01.res.87.1.66] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Although systemic administration of NO donors has been shown to attenuate the development of neointimal hyperplasia in the balloon injury model, this strategy has not been tested in a model of allograft vasculopathy. In this study, we investigated the effect of FK409, a spontaneous NO releaser, on the development of allograft vasculopathy, using a rat aortic transplant model. Thoracic aortas from ACI rats were transplanted heterotopically into the abdominal aorta of Wistar-Furth rats. Postoperatively, recipients received FK409 orally every 8 hours from the day of transplantation to the time of euthanization. Morphometric and immunohistochemical analyses were performed on the aortic grafts 8 weeks after transplantation. Control allografts showed severe neointimal hyperplasia, which consists mainly of alpha-actin-containing vascular smooth muscle cells. The FK409-treated allografts showed a dose-dependent reduction (statistically significant compared with the control) in the neointimal thickness as the dose increased from 1 to 10 mg/kg (thrice per day). However, there was no significant difference in the neointimal thickness between groups treated with 10 and with 20 mg/kg. FK409 treatment (10 mg/kg) caused a significant decrease in DNA synthesis (5-bromo-2-deoxyuridine [BrdU] uptake), an increase in DNA fragmentation (terminal deoxynucleotidyltransferase-mediated uridine nick-end labeling [TUNEL]), and upregulation of Fas expression, in the neointimal vascular smooth muscle cells. These data suggest that FK409 attenuates the allograft vasculopathy in a rat aortic transplant model.
Collapse
|
67
|
Yasin B, Pang M, Turner JS, Cho Y, Dinh NN, Waring AJ, Lehrer RI, Wagar EA. Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis 2000; 19:187-94. [PMID: 10795591 DOI: 10.1007/s100960050457] [Citation(s) in RCA: 140] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide microplate assay was adapted to screen for the ability of 20 host-defense peptides to inactivate herpes simplex virus type 1 and type 2. The procedure required minimal amounts of material, was reproducible, and was confirmed with standard antiviral testing techniques. In screening tests, with the exception of melittin, a highly cytotoxic and hemolytic peptide found in bee venom, the alpha-helical peptides in our test panel (magainins, cecropins, clavanins, and LL-37) caused little viral inactivation. Several beta-sheet peptides (defensins, tachyplesin, and protegrins) inactivated one or both viruses, sometimes with remarkable selectivity. Two peptides were identified as having antiviral activity against both viruses, indolicidin (a tryptophan-rich peptide from bovine neutrophils) and brevinin-1 (a peptide found in frog skin). The antiviral activity of these two peptides was confirmed with standard antiviral assays. Interestingly, the antiviral activity of brevinin-1 was maintained after reduction and carboxamidomethylation, procedures that abolished its otherwise prominent hemolytic and cytotoxic effects.
Collapse
|
68
|
Mulligan K, Grunfeld C, Tai VW, Algren H, Pang M, Chernoff DN, Lo JC, Schambelan M. Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndr 2000; 23:35-43. [PMID: 10708054 DOI: 10.1097/00126334-200001010-00005] [Citation(s) in RCA: 238] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Although protease inhibitor (PI) therapy has improved the clinical status of patients with HIV infection, concerns have arisen that such treatment may have deleterious effects on glucose control, lipid metabolism, and body fat distribution. To determine whether initiation of PI therapy uniquely affects glucose and lipid metabolism, we analyzed paired data in HIV-infected patients before and after beginning antiretroviral therapy that included a PI (PI; N = 20) or lamivudine (3TC) but no PI (3TC; N = 9); and a control group on stable regimens that included neither of these agents (CONT: N = 12). Measurements included fasting glucose; insulin; triglycerides; total, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol; HIV RNA; CD4+ lymphocytes; weight; and total and regional body composition. Neither weight nor total or regional fat content changed significantly in any group during the period of observation. Nonetheless, in patients beginning PI therapy, there were significant increases in glucose (+9+/-3 mg/dl; p = .0136), insulin (+12.2+/-4.9 U/ml; p = .023), triglycerides (+53+/-17 mg/dl; p = .0069), and total and LDL cholesterol (+32+/-11 and +18+/-5 mg/dl; p = .0082 and .0026, respectively). None of these parameters changed significantly in the 3TC or CONT groups. The PI and 3TC groups experienced comparable increases in CD4+ lymphocytes, suggesting that the observed metabolic effects may be associated with PIs uniquely, rather than improvement in clinical status. However, it is also possible that the metabolic effects of PIs are associated with more effective viral suppression, because a greater proportion of patients in the PI group achieved undetectable levels of virus. We conclude that changes in glucose and lipid metabolism are induced by PI therapy in the absence of significant changes in weight or fat distribution. Longer periods of follow-up will be required to determine the clinical significance of these changes. However, at the moment, the risks associated with these metabolic effects do not appear to outweigh improvements in survival seen with PI therapy.
Collapse
|
69
|
Khovidhunkit W, Memon RA, Shigenaga JK, Pang M, Schambelan M, Mulligan K, Feingold KR, Grunfeld C. Plasma platelet-activating factor acetylhydrolase activity in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 1999; 48:1524-31. [PMID: 10599983 DOI: 10.1016/s0026-0495(99)90240-8] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Abstract
Platelet-activating factor (PAF) acetylhydrolase (PAF-AH) catalyzes the hydrolysis of PAF, a mediator of inflammation, as well as other biologically active oxidized phospholipids. In humans, plasma PAF-AH activity is bound to low-density lipoprotein (LDL) and high-density lipoprotein (HDL). Higher levels of plasma PAF-AH activity have been found in a variety of diseases, and are thought to be a defense mechanism against the toxic effects of PAF and oxidized phospholipids. We studied plasma PAF-AH activity in patients with human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS), a disease characterized by chronic HIV infection and a systemic host response. Plasma PAF-AH activity was significantly greater in AIDS patients compared with control subjects (25.2 +/- 2.0 v 17.0 +/- 0.8 nmol/min/mL, P < .001). The higher levels of plasma PAF-AH activity were found in LDL (28.2 +/- 2.2 v 18.3 +/- 1.0 nmol/min/mL for AIDS v controls, respectively, P = .0005), but not in HDL. Plasma PAF-AH activity in AIDS correlated with circulating interferon alfa (r = .575, P = .005) and plasma triglycerides (r = .556, P < .0025). The presence of secondary infection in AIDS did not significantly change plasma PAF-AH activity. The initiation of a new antiretroviral regimen with either a protease inhibitor or the nucleoside analog lamivudine did not significantly decrease plasma PAF-AH activity, despite successful suppression of HIV RNA levels. Plasma PAF-AH activity may be a sensitive marker of the host response to infection, and the higher levels of plasma and LDL-associated PAF-AH activity in patients with HIV infection and AIDS may be a physiological response to protect the host against oxidative injury from PAF and oxidized phospholipids.
Collapse
|
70
|
Takeuchi T, Tsuzaka K, Pang M, Abe T. Defective signal transduction via TCR-CD3 complex in patients with systemic lupus erythematosus. Intern Med 1999; 38:169. [PMID: 10225676 DOI: 10.2169/internalmedicine.38.169] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
71
|
de Laszlo SE, Visco D, Agarwal L, Chang L, Chin J, Croft G, Forsyth A, Fletcher D, Frantz B, Hacker C, Hanlon W, Harper C, Kostura M, Li B, Luell S, MacCoss M, Mantlo N, O'Neill EA, Orevillo C, Pang M, Parsons J, Rolando A, Sahly Y, Sidler K, O'Keefe SJ. Pyrroles and other heterocycles as inhibitors of p38 kinase. Bioorg Med Chem Lett 1998; 8:2689-94. [PMID: 9873604 DOI: 10.1016/s0960-894x(98)00495-8] [Citation(s) in RCA: 104] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Investigation of furans, pyrroles and pyrazolones identified 3-pyridyl-2,5-diaryl-pyrroles as potent, orally bioavailable inhibitors of p38 kinase. 3-(4-pyridyl-2-(4-fluoro-phenyl)-5-(4-methylsulfinylphenyl)-pyrrol e (L-167307) reduces secondary paw swelling in the rat adjuvant arthritis model: ID50 = 7.4 mg/kg/b.i.d.
Collapse
|
72
|
Tsuzaka K, Takeuchi T, Onoda N, Pang M, Abe T. Mutations in T cell receptor zeta chain mRNA of peripheral T cells from systemic lupus erythematosus patients. J Autoimmun 1998; 11:381-5. [PMID: 9802920 DOI: 10.1006/jaut.1998.0223] [Citation(s) in RCA: 45] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown aetiology. Although it has been reported that T cells might be responsible for the pathogenesis of SLE, it remains unclear whether immune aberrations of SLE T cells are the primary event in this pathological process. We have recently reported that tyrosine phosphorylation and expression of the T cell receptor zeta chain (TCR zeta) was significantly decreased in SLE T cells and that two SLE patients exhibited a 36 bp, exon 7 deletion of the TCR zeta mRNA. To investigate further common mutations in TCR zeta mRNA among SLE patients, mRNA was isolated from the peripheral blood T cells of two normal controls, two systemic sclerosis (SSc) patients, and eight SLE patients. TCR zeta cDNA was amplified by RT-PCR. Five out of the eight SLE patients exhibited abnormal migration patterns of the TCR zeta cDNA in PCR single stranded conformational polymorphism analysis. PCR products were ligated into pUC18 and five clones obtained were sequenced. Analysis of the nucleotide sequences revealed that all of the five pUC18 clones from the normal controls and SSc patients had the normal nucleotide sequence, whereas all eight SLE patients had mutations in TCR zeta cDNA accompanied by predicted amino acid substitutions. Mutations found in six of these patients corresponded to those of the third immunoreceptor tyrosine-based activation motif (ITAM) domain or the GTP/GDP binding site in TCR zetaThus, these mutations in TCR zeta mRNA could be responsible for the decreased expression of the TCR zeta protein in SLE T cells.
Collapse
|
73
|
Frantz B, Klatt T, Pang M, Parsons J, Rolando A, Williams H, Tocci MJ, O'Keefe SJ, O'Neill EA. The activation state of p38 mitogen-activated protein kinase determines the efficiency of ATP competition for pyridinylimidazole inhibitor binding. Biochemistry 1998; 37:13846-53. [PMID: 9753474 DOI: 10.1021/bi980832y] [Citation(s) in RCA: 160] [Impact Index Per Article: 6.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
The serine/threonine kinase p38 is a ubiquitous, highly conserved, stress responsive, signal-transducing enzyme. It regulates the production of proinflammatory mediators and is the target of the cytokine synthesis inhibitory pyridinylimidazoles. We have expressed human p38 in Drosophila S2 cells and characterized preparations of mixed unphosphorylated/monophosphorylated (inactive) and homogeneously diphosphorylated (active) forms of the enzyme. We observed that only the active preparation of the enzyme has significant kinase activity when assayed using an ATF2-GST fusion protein as the substrate. We determined that the value of KM[ATP] in this reaction is 25 microM and that the pyridinylimidazole inhibitor of p38 kinase activity, SB203580, competes with ATP. We have found that a tritiated pyridinylimidazole, SB202190, has an equal affinity for both the active and inactive forms of the enzyme and that SB203580 competes with it equally well for binding to either form of the enzyme. However, ATP can compete with the tritiated inhibitor for binding to only the active form of the enzyme. Further, we demonstrate in vivo that at concentrations consistent with its IC50 as a cytokine inhibitor, SB203580 can inhibit stimulus-induced phosphorylation of p38 at the Thr-Gly-Tyr activation motif. Our observations suggest that pyridinylimidazoles may block the biological activity of p38 kinase by binding to the inactive form of p38 and reducing its rate of activation. Under these conditions, ATP would not effectively compete with the inhibitors in vivo.
Collapse
|
74
|
Takeuchi T, Tsusaka K, Pang M, Abe T. [Physiopathology of autoimmune diseases--recent findings. 2) Analysis of abnormalities of T cell receptor proximal signal transduction in systemic erythematodes]. NIHON NAIKA GAKKAI ZASSHI. THE JOURNAL OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE 1998; 87:1724-8. [PMID: 9816838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
|
75
|
Pang M, Abe T, Fujihara T, Mori S, Tsuzaka K, Amano K, Koide J, Takeuchi T. Up-regulation of alphaEbeta7, a novel integrin adhesion molecule, on T cells from systemic lupus erythematosus patients with specific epithelial involvement. ARTHRITIS AND RHEUMATISM 1998; 41:1456-63. [PMID: 9704645 DOI: 10.1002/1529-0131(199808)41:8<1456::aid-art16>3.0.co;2-0] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To determine the possible role of a novel integrin, alphaEbeta7, in the pathogenesis of systemic lupus erythematosus (SLE). METHODS Expression of alphaEbeta7 was examined on peripheral blood lymphocytes (PBL) from normal subjects (n = 25) and patients with SLE (n = 31), primary Sjogren's syndrome (n = 7), or polymyositis/dermatomyositis (n = 8) by cytofluorometry and/or immunoprecipitation. Adhesion of alphaEbeta7+ T cells to HSG epithelial cells was investigated using a confocal image analyzer. RESULTS After phytohemagglutinin stimulation, expression of alphaEbeta7 on PBL, especially on CD8+ T cells, was significantly higher in SLE patients than in normal subjects (P<0.01). Elevated alphaEbeta7 expression was associated with the presence of oral ulcers or serositis (P<0.05). Activated SLE T cells with enhanced alphaEbeta7 expression strongly adhered to HSG; this adhesion was partially blocked by anti-alphaEbeta7. CONCLUSION Expression and adhesion of alphaEbeta7 on activated PBL was significantly increased in patients with SLE with epithelial involvement. This suggests a role of this novel integrin in tissue-specific retention of activated PBL, due to increased alphaEbeta7-E-cadherin interaction, which may contribute to epithelial inflammation.
Collapse
|